1. Home
  2. CTGO vs BCYC Comparison

CTGO vs BCYC Comparison

Compare CTGO & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Contango ORE Inc.

CTGO

Contango ORE Inc.

HOLD

Current Price

$29.16

Market Cap

382.6M

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$5.60

Market Cap

456.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTGO
BCYC
Founded
2009
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
382.6M
456.4M
IPO Year
2010
2019

Fundamental Metrics

Financial Performance
Metric
CTGO
BCYC
Price
$29.16
$5.60
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$19.10
AVG Volume (30 Days)
230.6K
372.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
51.12
42.91
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.85
$5.03
52 Week High
$34.38
$11.79

Technical Indicators

Market Signals
Indicator
CTGO
BCYC
Relative Strength Index (RSI) 50.42 41.61
Support Level $25.47 $5.03
Resistance Level $29.55 $7.14
Average True Range (ATR) 1.57 0.31
MACD -0.00 0.01
Stochastic Oscillator 74.00 47.27

Price Performance

Historical Comparison
CTGO
BCYC

About CTGO Contango ORE Inc.

Contango Ore Inc operates in the United States. The company is engaged in the exploration of gold, silver, and copper ores in the State of Alaska. The company's focus is the exploration of a mineral lease with the Native Village of Tetlin whose governmental entity is the Tetlin Tribal Council for the exploration of minerals near Tok, Alaska. It has formed a joint venture to advance exploration of the Tetlin Property, which is prospective for gold and associated minerals. The Peak Gold JV Property is located in the Tetlin Hills and Mentasta Mountains of eastern interior Alaska. Its exploration projects are Lucky Shot, Johnson Tract, Eagle, Hona, Shamrock, and Triple Z.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: